Bone Health

Latest News

blood stream
Phase 1 Study Finds Comparable PK, PD Parameters in Biosimilar GP40141 vs Reference Romiplostim

November 25th 2023

A phase 1 analysis confirms that romiplostim biosimilar candidate GP40141 has comparable pharmacokinetic (PK) and pharmacodynamic (PD) parameters in healthy volunteers compared with the reference product.

Eye on Pharma banner
Eye on Pharma: Denosumab Biosimilar Data; COA Forms New Committee; IGBA and WHO Collaborate

November 8th 2023

bone cancer | Image credit: catalin -
Denosumab Biosimilar Demonstrates Positive Safety Results in Chinese Study

November 7th 2023

an older woman and a nurse smile at the camera
Biosimilar Teriparatide Improves BMD for Patients With Osteoporosis, Study Finds

August 24th 2023

biosimilar check in banner
Biosimilars Check In: Vegzelma Launch, BLA Acceptances, China Approval

April 26th 2023

Latest CME Events & Activities

More News

© 2023 MJH Life Sciences

All rights reserved.